Ipamorelin Research Ipamorelin was first characterized as a pentapeptide that releases growth hormone from primary rat pituitary cells with a receptor profile comparable to GHRP-6, while leaving ACTH, cortisol, prolactin, and thyroid-stimulating hormone levels largely unchanged in the models tested [1]
Clinically significant residual gastric volume (RGV) served as the studys primary outcome
Diabetologia 36:741744 Nauck MA, Niedereichholz U, Ettler R, Holst JJ, rskov C, Ritzel R, Schmiegel WH (1997) Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
And Ive changed nothing, other than retatrutide
10.1007/s11655-020-3205-5 115 WangX